7:01 AM ET
8-K
Investor Presentation
Glaukos Investor Presentation
Glaukos Corporation filed a formal investor presentation dated November 2026 to be used in meetings with investors and stakeholders. The presentation covers the company's strategic outlook, including the commercialization of its iDose TR and Epioxa therapies.